Anlon Healthcare Ltd.

133.99

-3.9 (-2.8%)

As on January 19, 2026
Sector
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap0 Cr
P/E Ratio26.02
Dividend YieldN/A
Trendline Performance

Unlock Stock of the Month

T&C*

Company Information


Market Insights
Open135.4
High137.81
NSE SymbolAHCL
Close133.99
Low133
BSE Symbol544497
Previous Years High/Low
1 Year High172.75
3 Year High172.75
5 Year High172.75
1 Year Low90.78
3 Year Low90.78
5 Year Low90.78

Technicals


IndicatorsValueSignal
5-DMA136.28Bearish
10-DMA141.35Bearish
20-DMA142.86Bearish
50-DMA146.76Bearish
100-DMA---
200-DMA---

Historical Performance


1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 26.02, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered price CAGR data is unavailable.
  • The stock carries a high beta of 1.4, implying higher volatility and elevated risk.
  • In the last financial year, the company reported an EBITDA of ₹327 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹1203 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 1460699.9
No. of Shares: 10902 (Approx)
Performance:46.1%
P/L: ₹460699.9
NIFTY Performance: 9.6%
1 day Top Gainers
SymbolChange%
JINDALSAW179.29(16%)
WELCORP787.75(7%)
JSWINFRA272.75(6%)
MASTEK2207.9(5%)
CGPOWER590(5%)
1 Day Top Losers
SymbolChange%
WIPRO245.95(-8%)
RBLBANK302.85(-7%)
IDBI98.64(-6%)
MRPL143.25(-5%)
GPPL173.21(-5%)
HBLENGINE756.3(-5%)
JUBLPHARMA994.5(-5%)
GODREJPROP1797.8(-5%)

Top Performing Stocks from the same sector


Mangalam Drugs And Organics Ltd.

105.5%

49.35

1 Month Performance

NGL Fine-Chem Ltd.

21.2%

1549.3

1 Month Performance

Ind-Swift Laboratories Ltd.

19.3%

111.44

1 Month Performance

Emcure Pharmaceuticals Ltd.

11.9%

1549.5

1 Month Performance

Zim Laboratories Ltd.

11.4%

79.01

1 Month Performance

Panacea Biotec Ltd.

10%

391.65

1 Month Performance

Kopran Ltd.

9.8%

142.66

1 Month Performance

Windlas Biotech Ltd.

9.7%

853.1

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month